Heart Failure

Professor Roy S. Gardner is a consultant cardiologist for the Scottish National Advanced Heart Failure Service at the Golden Jubilee National Hospital in Glasgow and an honorary professor at the University of Glasgow. He has a specialist interest and active research profile in advanced heart failure, cardiac transplantation, and complex devices. He is the past chair of the British Society for Heart Failure (BSH) and was awarded a lifetime Fellowship from the society 2023. He also serves on several European Society of Cardiology (ESC) committees and was the Taskforce Coordinator for the 2021 and 2023 ESC Heart Failure Guidelines.Professor Theresa A. McDonagh is a consultant cardiologist at King's College London. Her research interests are in clinical heart failure, in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers. Prof McDonagh is currently chair of the Clinical Section of the Heart Failure Association of the ESC and clinical lead for the National Heart Failure Audit.Dr Daniel J. Doherty is a clinical research fellow at the University of Glasgow and cardiology speciality registrar in the west of Scotland. His interests include heart failure, complex devices and heart rhythm management, and he is currently undertaking a PhD examining the use of novel biomarkers for the detection of congestion in heart failure.Dr Niki L. Walker is a consultant cardiologist at the Scottish Adult Congenital Cardiac Service for Intervention and Cardiac Obstetrics at Golden Jubilee National Hospital. She has written numerous research works as part of the ESC.

• Section I - General Introduction 1: Definition of heart failure: basic epidemiology and pathophysiology Section II - Chronic Heart Failure 2: Diagnosis and investigation 3: Estimating prognosis 4: Non-pharmacological management 5: Pharmacological management 6: Device therapy 7: Revascularisation 8: Cardiac transplantation 9: Mechanical circulatory support Section III - Heart failure and co-morbid/special conditions 10: The patient with heart failure and angina 11: The patient with heart failure and arrhythmias 12: The patient with heart failure and arthritis 13: The patient with heart failure and cancer 14: The patient with heart failure and cardiomyopathy 15: The patient with heart failure and congenital heart disease 16: The patient with heart failure and diabetes mellitus 17: The patient with heart failure and electrolyte disorders 18: The patient with heart failure and infiltrative disease 19: The patient with heart failure and iron deficiency / anaemia 20: The patient with heart failure and myocarditis 21: The patient with heart failure and obstructive lung disease 22: The patient with heart failure and pregnancy 23: The patient with heart failure and renal dysfunction 24: The patient with heart failure and valvular disease Section IV - Acute heart failure 25: Definition, aetiology, differing presentations and consequences 26: Management Section V - Procedures 27: Central venous cannulation 28: Swan Ganz catheterisation 29: Cardiac biopsy 30: IABP insertion 31: Cardiopulmonary exercise testing Section VI - Detailed pharmacology and evidence base for chronic heart failure 32: ACE inhibitors 33: ARNI 34: ARBs 35: Beta-adrenoreceptor antagonists 36: Mineralocorticoid receptor antagonists 37: SGLT2 inhibitors 38: Diuretics and aquaretics 39: Rate limiting agents 40: Inotropes and vasopressors 41: Vasodilators Section VI - Multiprofessional heart failure care 42: Heart failure services 43: Palliative care